The appointment of an external CEO, Michel Lagarde, and the splitting of the CEO/Chair roles signifies a major leadership restructuring.
Filing excerpt
On June 1, 2026, the Company announced the appointment of Michel Lagarde as President and Chief Executive Officer of the Company, effective August 31, 2026 (the “Start Date”), to replace Mr. Green in those roles.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
Competitors
Competitors named
sec-8krestructuringGet every 8-K signal for West Pharmaceutical Services and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at West Pharmaceutical Services this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/addf785e-106d-473d-bcac-7bab12e848e4 returns this record as JSON. POST /v1/companies/enrich returns every signal for westpharma.com.
{
"signal_id": "addf785e-106d-473d-bcac-7bab12e848e4",
"signal_type": "sec-8k",
"signal_subtype": "restructuring",
"detected_at": "2026-06-02T08:18:23.497+00:00",
"company": {
"name": "West Pharmaceutical Services",
"domain": "westpharma.com"
},
"data": {
"detail": "The appointment of an external CEO, Michel Lagarde, and the splitting of the CEO/Chair roles signifies a major leadership restructuring. New CEOs typically review strategy, budgets, and key vendor relationships within their first 90 days, creating a significant opportunity for new partners to engage and influence future initiatives.",
"metrics": {
"timeframe": "next_quarter"
},
"summary": "West Pharma appoints new CEO Michel Lagarde, effective Aug 31, 2026, triggering C-suite and Board restructuring.",
"excerpts": "On June 1, 2026, the Company announced the appointment of Michel Lagarde as President and Chief Executive Officer of the Company, effective August 31, 2026 (the “Start Date”), to replace Mr. Green in those roles.",
"relevance": 0.95,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/wst-20260531.htm",
"filing_date": "2026-06-01",
"filing_year": 2026,
"fiscal_year_end": "05/31",
"sales_relevance": "Change management needs",
"signal_category": "workforce",
"vendors_mentioned": [
"JLL Partners"
],
"competitors_mentioned": [
"Thermo Fisher Scientific, Inc.",
"Patheon N.V.",
"Vertex Pharmaceuticals"
]
}
}
curl https://signals.autobound.ai/v1/signals/addf785e-106d-473d-bcac-7bab12e848e4 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"westpharma.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.